Opioid Use Disorder (OUD) Market Size 2020

The global opioid use disorder (OUD) market size is projected to reach USD 4.50 billion by 2026, exhibiting a CAGR of 10.8% during the forecast period. Increasing addiction to opioids across the globe will be the central force driving the growth of this market, shares Fortune Business Insights™ in its recent report

Highlights of the Report:

· In-depth analysis of various insights, namely, Opioid Use Disorder (OUD) Market trends, growth drivers, opportunities, and other related challenges.

· Comprehensive details of key market players, their core competencies, and Opioid Use Disorder (OUD) Market share.

· The potency of suppliers and buyers to make better business decisions.

· Lists out the market size in terms of volume.

Please visit: https://www.fortunebusinessinsights.com/opioid-use-disorder-oud-market-102674

Detailed Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1. Pipeline Analysis

4.2. New Product Launches

4.3. Statistics of Opioid Use Disorder

4.4. Industry Developments Such as Mergers, Acquisitions, and Collaborations

5. Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Drug Class

5.2.1. Buprenorphine

5.2.2. Methadone

5.2.3. Naltrexone

5.3. Market Analysis, Insights and Forecast – By Route of Administration

5.3.1. Oral

5.3.2. Parenteral

5.4. Market Analysis, Insights and Forecast – By Distribution Channel

5.4.1. Hospitals Pharmacies

5.4.2. Retail Pharmacies & Stores

5.4.3. Online Pharmacies

5.5. Market Analysis, Insights and Forecast – By Region

5.5.1. North America

5.5.2. Europe

5.5.3. Asia Pacific

5.5.4. Rest of the World

6. North America Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026

6.1. Key Findings / Summary

6.2. Market Analysis – By Drug Class

6.2.1. Buprenorphine

6.2.2. Methadone

6.2.3. Naltrexone

6.3. Market Analysis – By Route of Administration

6.3.1. Oral

6.3.2. Parenteral

6.4. Market Analysis – By Distribution Channel

6.4.1. Hospitals Pharmacies

6.4.2. Retail Pharmacies & Stores

6.4.3. Online Pharmacies

6.5. Market Analysis – By Country

6.5.1. U.S.

6.5.2. Canada

7. Europe Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026

7.1. Key Findings / Summary

7.2. Market Analysis – By Drug Class

7.2.1. Buprenorphine

7.2.2. Methadone

7.2.3. Naltrexone

7.3. Market Analysis – By Route of Administration

7.3.1. Oral

7.3.2. Parenteral

7.4. Market Analysis – By Distribution Channel

7.4.1. Hospitals Pharmacies

7.4.2. Retail Pharmacies & Stores

7.4.3. Online Pharmacies

7.5. Market Analysis – By Country/ sub-region

7.5.1. U.K.

7.5.2. Germany

7.5.3. France

7.5.4. Spain

7.5.5. Italy

7.5.6. Scandinavia

7.5.7. Rest of Europe

8. Asia Pacific Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026

8.1. Key Findings / Summary

8.2. Market Analysis – By Drug Class

8.2.1. Buprenorphine

8.2.2. Methadone

8.2.3. Naltrexone

8.3. Market Analysis – By Route of Administration

8.3.1. Oral

8.3.2. Parenteral

8.4. Market Analysis – By Distribution Channel

8.4.1. Hospitals Pharmacies

8.4.2. Retail Pharmacies & Stores

8.4.3. Online Pharmacies

8.5. Market Analysis – By Country

8.5.1. Japan

8.5.2. China

8.5.3. India

8.5.4. Australia

8.5.5. Southeast Asia

8.5.6. Rest of Asia Pacific